Try our Advanced Search for more refined results
Belcher Pharmaceuticals LLC
-
Trial | Filed: May 13, 2024 | Entered: May 13, 2024 Rubin v. Sterling Knight Pharmaceuticals LLC et al
Qui Tam (31 U.S.C. § 3729(a)) | Florida Middle
Proposed verdict form filed
PROPOSED verdict form filed byBelcher Pharmaceuticals, LLC, Arun Kapoor, Sterling Knight Pharmaceuticals, LLC, Mihir Taneja. (Darken, Kevin)
-
Motion | Filed: May 13, 2024 | Entered: May 13, 2024 Rubin v. Sterling Knight Pharmaceuticals LLC et al
Qui Tam (31 U.S.C. § 3729(a)) | Florida Middle
In Limine
MOTION In Limine to Exclude DHA/Tricare Summary Spreadsheet Relator Ex 131(a)-(c) regarding Plaintiff's EX 131a-c and 130 by Belcher Pharmaceuticals, LLC, Arun Kapoor, Sterling Knight Pharmaceuticals, LLC, Mihir Taneja. (Attachments: # 1 Exhibit Pltf EX 131a-c _ Excel spreadsheet, # 2 Exhibit Pltf EX 130 _ Zakaryan Declaration)(Albritton, A.)
-
Trial | Filed: May 13, 2024 | Entered: May 13, 2024 Rubin v. Sterling Knight Pharmaceuticals LLC et al
Qui Tam (31 U.S.C. § 3729(a)) | Florida Middle
Proposed Jury Instructions
Proposed Jury Instructions by Belcher Pharmaceuticals, LLC, Arun Kapoor, Sterling Knight Pharmaceuticals, LLC, Mihir Taneja. (Darken, Kevin)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login